In the midterm, the company achieved significant year-over-year revenue and profit growth across the entire company. Revenue was 1,969 million yen, operating income was 193 million yen, ordinary income was 186 million yen, and midterm net income was 118 million yen. By segment, the semiconductor materials, sanitary inspection instruments, and PIM businesses each recorded revenue and profit increases. Going forward, attention will be paid to pre-purchase demand and market trends. Evaluation of new technologies such as CellTune Gel has also begun.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4241","jir_company_name":"atect corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4241-20261113-02.pdf","jir_short_summary":"In the midterm, the company achieved significant year-over-year revenue and profit growth across the entire company. Revenue was 1,969 million yen, operating income was 193 million yen, ordinary income was 186 million yen, and midterm net income was 118 million yen. By segment, the semiconductor materials, sanitary inspection instruments, and PIM businesses each recorded revenue and profit increases. Going forward, attention will be paid to pre-purchase demand and market trends. Evaluation of new technologies such as CellTune Gel has also begun.","jir_summary":"### Performance Overview\nIn the midterm of VISION 30S, all three business segments achieved substantial year-over-year revenue and profit growth. The gross profit margin remained high at 41.8%. Although SG&A expenses increased, operating income reached a record high due to revenue growth, lower raw material costs, and productivity improvements. The semiconductor materials, sanitary inspection instruments, and PIM businesses performed steadily, delivering significant improvements compared with the same period last year.\n\n### Outlook and Risks\nThe document notes that pre-purchase demand driven by Middle East tensions and careful monitoring of market trends are necessary, so attention is needed for second-half trends. While SG&A expenses rose, profitability trends are improving due to increases in gross profit. Evaluation of commercialization for new technologies, such as the start of sample provision for evaluation of CellTune Gel, continues to progress.","jir_financial_highlights":"Revenue: 1,969 (Year-over-Year (YoY) 20.7% increase)\nGross Profit: 823 (Year-over-Year (YoY) 23.3% increase)\nOperating Income: 193 (Year-over-Year (YoY) 97.5% increase)\nOrdinary Income: 186 (Year-over-Year (YoY) 80.6% increase)\nMidterm Net Income: 118 (Year-over-Year (YoY) 43.3% increase)","jir_category":"","jir_hashtags":"#atect, #MidtermPerformanceSummary","jir_key_figures":"Revenue: 1,969 million yen\nOperating Income: 193 million yen\nMidterm Net Income: 118 million yen","jir_meta_title":"atect corporation VISION 30S Midterm Performance Summary\uff5c2Q FY2026","jir_meta_description":"Analysis of atect corporation's VISION 30S midterm performance summary. Revenue 1,969 million yen, operating income 193 million yen; details on segment revenue and profit growth and focus areas going forward, including new technologies like CellTune Gel.","jir_og_title":"atect corporation VISION 30S Midterm Performance Summary\uff5c2Q FY2026","jir_og_description":"atect corporation's VISION 30S midterm performance summary. Achieved significant revenue and profit growth; summary of drivers by segment and outlook. Evaluation of CellTune Gel is underway.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2026 Mar 2Q\\\",\\\"FY2027 Mar 2Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[1631,1969]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2026 Mar 2Q\\\",\\\"FY2027 Mar 2Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[97,193]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue by Business\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Semiconductor Materials\\\",\\\"Sanitary Inspection Instruments\\\",\\\"PIM\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[? , ?, ?]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Gross Margin & Operating Margin\", \"n\/a\": \"Data unknown, empty dataset\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Plan vs Actual for Current Period\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2026 Mar 2Q\\\",\\\"FY2027 Mar 2Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[1631,1969]},{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[97,193]}]},\\\"options\\\":{}}\"}]","ir_related_company":61101,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-153241","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n